Allergy Therapeutics “2022 is going to be a pivotal year”
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has provided a trading update for the six months ended 31 December 2021 ahead of its